Maven Securities’s Forte Biosciences FBRX Stock Holding History

Maven Securities’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,335	Closed	-$3.04M	–	1209
2020 Q4	$3.04M	Buy	+3,335	New	+$3.13M	0.3%	79

Other funds holding FBRX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maven Securities's FBRX Position: Q1 2021 in Review

Maven Securities sold out of Forte Biosciences (FBRX) in Q1 2021, closing a stake of 3,335 shares — an estimated $3.04M sold.

Maven Securities first reported a position in FBRX in Q4 2020 and held it in 1 quarter. The position peaked at $3.04M in Q4 2020. 62 funds tracked by Wall St. Rank hold FBRX as of Q1 2021.

Maven Securities reported no remaining Forte Biosciences position as of Q1 2021 after selling out during the quarter.
Maven Securities sold 3,335 Forte Biosciences shares in Q1 2021, an estimated $3.04M.
Maven Securities first reported a position in Forte Biosciences in Q4 2020 and held it in 1 quarter.
Maven Securities's Forte Biosciences position peaked at $3.04M in Q4 2020.
62 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2021.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.